认知配准与自由手经会阴前列腺穿刺活检对双参数磁共振靶向病灶在初诊男性中的诊断路径结局:CRAFT单中心研究
该单中心前瞻性记录队列纳入2018年7月至2023年3月初诊男性,经双参数磁共振后于穿刺前会议风险分层,行仅靶向或靶向联合系统穿刺。1251例活检中前列腺癌检出84%、临床显著癌70.6%,并发症率0.7%;作者认为认知配准自由手经会阴穿刺安全、可行且经济有效。
要点
- 初诊男性双参数磁共振后风险分层,仅靶向穿刺前列腺癌检出86.2%、临床显著癌76.5%。
- 靶向联合系统穿刺前列腺癌检出78.7%、临床显著癌56.3%。
- 总体活检并发症率0.7%,作者认为该路径安全、可行且经济有效。
核心结论
- 穿刺前双参数磁共振联合穿刺前会议风险分层、认知靶向与自由手经会阴前列腺穿刺,前列腺癌检出率高,与其他研究相当。
- 作者认为这些数据支持认知配准自由手经会阴前列腺穿刺是安全、可行且经济有效的。
研究设计与样本
- 单中心连续系列初诊男性,2018年7月至2023年3月前瞻性记录。
- 穿刺前会议根据双参数磁共振进行风险分层,决定行仅靶向穿刺或靶向联合系统穿刺。
- 活检常规在门诊局部麻醉下进行,不使用抗生素预防。
- 主要结局为总体前列腺癌和临床显著前列腺癌(国际泌尿病理学会分级分组≥2)检出。
主要发现
- 1251例活检中,前列腺癌检出84%,临床显著癌检出70.6%。
- 仅靶向穿刺组前列腺癌检出86.2%、临床显著癌检出76.5%。
- 靶向联合系统穿刺组前列腺癌检出78.7%、临床显著癌检出56.3%。
- 活检后并发症率为0.7%。
临床怎么用
- 作者认为认知配准自由手经会阴前列腺穿刺可作为安全、可行且经济有效的路径。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Enhanced histological detection of clinically significant prostate cancer is the goal of the prebiopsy imaging pathway. Risk stratification at a prebiopsy meeting can facilitate optimization of lesion targeting. We aimed to evaluate the feasibility of cognitive registration, freehand transperineal prostate biopsy in a biopsy-naïve population following biparametric MRI for the detection of clinically significant disease (International Society of Urological Pathology Grade Group ≥2). MATERIALS AND METHODS: A consecutive series of biopsy-naïve men, prospectively recorded between July 2018 and March 2023, were risk-stratified at our prebiopsy meeting following biparametric MRI to undergo either target-only biopsy or target with systematic biopsy. Biopsies were routinely performed under local anesthesia and without antibiotic prophylaxis in the outpatient setting. Overall prostate cancer and clinically significant prostate cancer detection were primary outcomes. RESULTS: Of 1251 biopsies, prostate cancer was detected in 84% and clinically significant disease in 70.6%. Prostate cancer and clinically significant disease were detected in 86.2% and 76.5% of target-only biopsies, respectively, and in 78.7% and 56.3% of target with systematic biopsies. Postbiopsy complication rate was 0.7%. CONCLUSIONS: Prebiopsy biparametric MRI with risk stratification at a prebiopsy meeting in the setting of cognitive targeting and freehand transperineal prostate biopsy yielded a high detection of prostate cancer that is comparable to other studies. These data support the use of cognitive registration, freehand transperineal prostate biopsy as safe, feasible, and cost-effective.
引用
- Fleville S, O'Neill C, Safar D, et al. Diagnostic Pathway Outcomes for Biparametric Magnetic Resonance Imaging-Targeted Lesions Using Cognitive Registration and Freehand Transperineal Prostate Biopsy in Biopsy-Naïve Men (CRAFT Single-Center Study). J Urol. 2024. PMID: 39190965. doi:10.1097/JU.0000000000004226
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。